Caitong International Asset Management’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
Other funds holding TPST
Caitong International Asset Management's TPST Position: Q2 2026 in Review
Caitong International Asset Management opened a new position in Tempest Therapeutics (TPST) in Q2 2026: 3 shares worth $3. The stake represents ﹤0.01% of the portfolio and ranks #2807 among its holdings.
3 funds tracked by Wall St. Rank hold TPST as of Q2 2026.
- Caitong International Asset Management held 3 shares of Tempest Therapeutics worth $3 as of Q2 2026.
- Tempest Therapeutics was a new Caitong International Asset Management position in Q2 2026.
- Tempest Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2807 holding.
- 3 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.
Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.